M. Lisovsky et al., FLT3 LIGAND STIMULATES PROLIFERATION AND INHIBITS APOPTOSIS OF ACUTE MYELOID-LEUKEMIA CELLS - REGULATION OF BCL-2 AND BAX, Blood, 88(10), 1996, pp. 3987-3997
Flt3/flk-2 ligand (flt3-L) is a potent costimulator of normal bone mar
row (BM) myeloid progenitors. Flt3-L is produced by BM stromal cells a
nd its receptor is expressed in the majority of acute myeloid leukemia
(AML) cases. Therefore, flt3-L may play a role in the paracrine and/o
r autocrine loops sustaining leukemic cell growth. We evaluated the ef
fects of recombinant human flt3-L on proliferation, apoptosis, and Bcl
-2 and Bax expression in primary AML cells and compared them with thos
e of stem cell factor (SCF). Mononuclear BM cells from patients with n
ewly diagnosed AML were cultured in serum-free conditions with flt3-L,
SCF, granulocyte colony-stimulating factor (G-CSF) and granulocyte ma
crophage-colony-stimulating factor (GM-CSF) alone and in combination.
In 9 of 10 samples, flt3-L significantly increased [H-3]thymidine upta
ke (geometric mean stimulation index, 7.5; range, 2.4 to 41.5). Flt3-L
also increased the number of AML blast colonies by 126% (range, 61% t
o 181%). In these 9 samples, flt3-L significantly enhanced the prolife
rative response triggered by G-CSF or GM-CSF. Flt3-L prevented apoptos
is in AML blasts. It reduced the number of apoptotic cells by 36% +/-
3.9% compared with control cultures. Combining flt3-L with G-CSF or GM
-CSF doubled the antiapoptotic effect. Cellular Bcl-2 and Bax levels w
ere determined separately for apoptotic and nonapoptotic cells by flow
cytometry. Cells undergoing spontaneous apoptosis had low Bcl-2 and h
igh Bax levels, whereas nonapoptotic cells had high Bcl-2 and low Bax
levels. Flt3-L alone or in combination with G-CSF or GM-CSF did not up
regulate Bcl-2. However, Bax expression decreased in viable cells in t
he presence of these cytokines and the lowest level was achieved when
a combination of flt3 and GM-CSF was used. Proliferative and viability
effects of flt3-L were similar to those of SCF. Our results demonstra
te that flt3-L acts as a stimulatory factor for primary AML cells. The
antiapoptotic effects of flt3-L or its combinations with G-CSF or GM-
CSF correlate with their ability to prevent upregulation of Bax. (C) 1
996 by The American Society of Hematology.